Hypertension Diagnostics Company Description
Hypertension Diagnostics can tell if your cardiovascular system is about to go snap, crackle, and pop. The company's noninvasive instruments measure the elasticity of arteries, helping physicians assess patients' risk for cardiovascular disease. Its CR-2000 Research System is marketed for research purposes to government agencies, pharmaceutical companies, academic research centers, and cardiovascular research centers worldwide; drug heavyweights AstraZeneca and Pfizer are among the system's users. The CVProfilor DO-2020 and the CVProfilor MD-3000 are intended for general physicians, cardiologists, and other health care practitioners in the US and abroad.
View the Comprehensive Company Description for Hypertension Diagnostics
The Company Description provides a historical perspective of Hypertension Diagnostics's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Hypertension Diagnostics's evolution in the marketplace.
